Home Financial Results

Financial Results

ICRA: Hospital sector continues to be under weather in Q2 FY2019

Operating margin drops from 15.0% in Q2 FY2018 to 13.3% In Q2 FY2019 Structurally, in the long term, underlying fundamentals continue to favour the sector The muted performance of the hospital sector continues in Q2 FY2019. The companies in...

Morepen Labs Reports Growth-filled Fourth Quarter to Close FY 2017-18 with a 25 Per...

New Delhi, May 18, 2018: Highlights 12M FY 2017-18 (Consolidated) Net profit rises by 25 per cent at Rs. 29.59 Crore. Net Sales Revenue up by 1.9 per cent at Rs. 598 crore. Domestic sales up by 21.3 per cent at Rs....

Strides posts Rs.532-cr net in fiscal 2015

Bengaluru, May 27, 2015 Drug firm Strides Arcolab has posted a net profit of Rs.532.3 crore for the 2015 financial year, riding on the back of a spate of acquisitions made in the year, coupled with renewed focus on re-entering...

Granules India’s Revenue from operation increases by 14% to INR 411 Cr.

Mumbai, February 09, 2018: Granules India Ltd., a growing pharmaceutical manufacturing company, announced today financial results for its third quarter ended 31st December, 2017.             Quarterly Financial Highlights of Q3FY18 Consolidated              Margins (%) Revenue:                    INR 411 Cr. EBITDA:                       INR 75 Cr.       ...

Narayana Hrudayalaya Limited Q1 FY19 Consolidated operating income at Rs 6,523 mn (y-o-y of...

Bengaluru, August 06, 2018: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, today announced its financial results for the first quarter (Q1 FY19) ended June 30th, 2018.  Financial Highlights for the Quarter (Q1 FY19) - Prepared in accordance with Ind...

Pharma exports to miss target

NEW DELHI, APRIL 25,2014: India’s pharmaceutical exports registered slowest growth in at least 15 years at 1.2 per cent to $14.84 billion last fiscal amid growing tension with the US over intellectual property rights related issues. As the...

Middle East and Africa pharma economy to reach US$38.8bn by 2021

CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing Amsterdam, August 15, 2018: CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are...

Taro Pharma Q1 profit up 23% to $67.3m; operational income dips 19%

New Delhi, August 12, 2018: Net sales during the quarter fell 4.2 percent to $154.6 million compared to $161.3 million in same period last fiscal. Taro Pharmaceutical Industries, the US subsidiary of Sun Pharma, has reported a 23.5 percent year-on-year growth...

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

New Delhi, September 30, 2014 - It will take a "few years" for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a "complex and large acquisition". Sun...

POLY MEDICURE LIMITED reports Fourth Quarter and Annual Results for FY 2015-16

New Delhi, May 19, 2016: POLY MEDICURE LIMITED, the leading manufacturers of medical devices and disposables under the brand name Polymed, announced its fourth quarterly results for quarter ending March 31, 2016 and Annual results besides providing other general...